Standard
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. / Pedersen, Tanja Xenia; Madsen, Marie; Nielsen, Nanna Maria Junker; Christoffersen, Christina; Vikeså, Jonas; Bro, Susanne; Hultgårdh-Nilsson, Anna; Nielsen, Lars Bo.
I:
Cardiovascular Research, Bind 98, Nr. 3, 01.06.2013, s. 352-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Pedersen, TX, Madsen, M, Nielsen, NMJ
, Christoffersen, C, Vikeså, J, Bro, S, Hultgårdh-Nilsson, A & Nielsen, LB 2013, '
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia',
Cardiovascular Research, bind 98, nr. 3, s. 352-9.
https://doi.org/10.1093/cvr/cvt049APA
Pedersen, T. X., Madsen, M., Nielsen, N. M. J.
, Christoffersen, C., Vikeså, J., Bro, S., Hultgårdh-Nilsson, A., & Nielsen, L. B. (2013).
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Cardiovascular Research,
98(3), 352-9.
https://doi.org/10.1093/cvr/cvt049Vancouver
Pedersen TX, Madsen M, Nielsen NMJ
, Christoffersen C, Vikeså J, Bro S o.a.
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Cardiovascular Research. 2013 jun. 1;98(3):352-9.
https://doi.org/10.1093/cvr/cvt049Author
Pedersen, Tanja Xenia ; Madsen, Marie ; Nielsen, Nanna Maria Junker ; Christoffersen, Christina ; Vikeså, Jonas ; Bro, Susanne ; Hultgårdh-Nilsson, Anna ; Nielsen, Lars Bo. / Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. I: Cardiovascular Research. 2013 ; Bind 98, Nr. 3. s. 352-9.
Bibtex
@article{f95cec699d344c289cadb9af04325b40,
title = "Osteopontin deficiency dampens the pro-atherogenic effect of uraemia",
abstract = "Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.",
author = "Pedersen, {Tanja Xenia} and Marie Madsen and Nielsen, {Nanna Maria Junker} and Christina Christoffersen and Jonas Vikes{\aa} and Susanne Bro and Anna Hultg{\aa}rdh-Nilsson and Nielsen, {Lars Bo}",
year = "2013",
month = jun,
day = "1",
doi = "10.1093/cvr/cvt049",
language = "English",
volume = "98",
pages = "352--9",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",
}
RIS
TY - JOUR
T1 - Osteopontin deficiency dampens the pro-atherogenic effect of uraemia
AU - Pedersen, Tanja Xenia
AU - Madsen, Marie
AU - Nielsen, Nanna Maria Junker
AU - Christoffersen, Christina
AU - Vikeså, Jonas
AU - Bro, Susanne
AU - Hultgårdh-Nilsson, Anna
AU - Nielsen, Lars Bo
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.
AB - Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.
U2 - 10.1093/cvr/cvt049
DO - 10.1093/cvr/cvt049
M3 - Journal article
C2 - 23455547
VL - 98
SP - 352
EP - 359
JO - Cardiovascular Research
JF - Cardiovascular Research
SN - 0008-6363
IS - 3
ER -
